Literature DB >> 11948056

Prognostic value of low-dose dobutamine echocardiography in patients with idiopathic dilated cardiomyopathy.

Jaroslaw Drozdz1, Maria Krzemińska-Pakula, Michal Plewka, Michal Ciesielczyk, Jaroslaw D Kasprzak.   

Abstract

STUDY
OBJECTIVES: Dobutamine echocardiography is widely used for the evaluation of myocardial contractile reserve. The purpose of the study was to determine the prognostic value of low-dose dobutamine echocardiography in patients with idiopathic dilated cardiomyopathy (IDCM). PATIENTS: The study group consisted of 77 consecutive patients with recently diagnosed IDCM (mean [+/- SD] age, 49 +/- 9 years; men, 82%) and left ventricular (LV) ejection fractions of < 40%.
INTERVENTIONS: Two-dimensional and Doppler echocardiographic variables were measured before and after the infusion of dobutamine at the rate of 10 microg/kg/min for 5 min. MEASUREMENTS AND
RESULTS: During a mean follow-up period of 63 +/- 7 months (range, 49 to 75 months) 30 patients (39%) died and five patients (6%) underwent successful heart transplantations. Using multivariate regression analysis, the only significant factors related to fatal outcome or the need for cardiac transplantation were the following: (1) LV end-systolic volume of > 150 mL after low-dose dobutamine infusion (odds ratio [OR], 2.2; confidence interval [CI], 1.2 to 4.1; p = 0.011); (2) no decrease of LV end-diastolic volume after dobutamine infusion (OR, 1.9; CI, 1.1 to 3.4; p = 0.031); (3) atrial fibrillation (OR, 2.7; CI, 1.4 to 5.3; p = 0.003); and (4) male gender (OR, 2.6; CI, 1.2 to 5.5; p = 0.017). A scoring system was proposed with one point assigned for each of the above-mentioned factors. The mortality rates for total scores of 0, 1, 2, 3, and 4 were 0%, 19%, 48%, 83%, and 100%, respectively.
CONCLUSION: The response of the LV to low-dose dobutamine infusion adds clinically valuable prognostic information to the evaluation of the patient with IDCM.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11948056     DOI: 10.1378/chest.121.4.1216

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  8 in total

1.  Low-dose dobutamine stress echocardiography predicts the improvement of left ventricular systolic function and long-term prognosis in patients with idiopathic dilated cardiomyopathy.

Authors:  Yoshihisa Matsumura; Jun Takata; Hiroaki Kitaoka; Tomoyuki Hamada; Makoto Okawa; Toru Kubo; Yoshinori Doi
Journal:  J Med Ultrason (2001)       Date:  2006-03       Impact factor: 1.314

2.  Calcium Upregulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID): a phase 2 trial of intracoronary gene therapy of sarcoplasmic reticulum Ca2+-ATPase in patients with advanced heart failure.

Authors:  Mariell Jessup; Barry Greenberg; Donna Mancini; Thomas Cappola; Daniel F Pauly; Brian Jaski; Alex Yaroshinsky; Krisztina M Zsebo; Howard Dittrich; Roger J Hajjar
Journal:  Circulation       Date:  2011-06-27       Impact factor: 29.690

3.  Calcium upregulation by percutaneous administration of gene therapy in cardiac disease (CUPID Trial), a first-in-human phase 1/2 clinical trial.

Authors:  Brian E Jaski; Mariell L Jessup; Donna M Mancini; Thomas P Cappola; Daniel F Pauly; Barry Greenberg; Kenneth Borow; Howard Dittrich; Krisztina M Zsebo; Roger J Hajjar
Journal:  J Card Fail       Date:  2009-04       Impact factor: 5.712

Review 4.  Stress-echocardiography in idiopathic dilated cardiomyopathy: instructions for use.

Authors:  Aleksandar N Neskovic; Petar Otasevic
Journal:  Cardiovasc Ultrasound       Date:  2005-02-10       Impact factor: 2.062

5.  Variability of longitudinal strain in left ventricular segments supplied by non-stenosed coronary artery: insights from speckle tracking analysis of dobutamine stress echocardiograms in patients with high coronary risk profile.

Authors:  Karina Wierzbowska-Drabik; Michał Plewka; Jarosław D Kasprzak
Journal:  Arch Med Sci       Date:  2016-06-14       Impact factor: 3.318

6.  Electrocardiographic and cardiac magnetic resonance imaging parameters as predictors of a worse outcome in patients with idiopathic dilated cardiomyopathy.

Authors:  Vinzenz Hombach; Nico Merkle; Jan Torzewski; Johann M Kraus; Markus Kunze; Oliver Zimmermann; Hans A Kestler; Jochen Wöhrle
Journal:  Eur Heart J       Date:  2009-07-24       Impact factor: 29.983

Review 7.  Role of echocardiography in diagnosis and risk stratification in heart failure with left ventricular systolic dysfunction.

Authors:  Quirino Ciampi; Bruno Villari
Journal:  Cardiovasc Ultrasound       Date:  2007-10-02       Impact factor: 2.062

Review 8.  Stress echocardiography in heart failure.

Authors:  Eustachio Agricola; Michele Oppizzi; Matteo Pisani; Alberto Margonato
Journal:  Cardiovasc Ultrasound       Date:  2004-07-30       Impact factor: 2.062

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.